Showing results (11-20 of 601) with videos related to
Sort By:
Pageof 61
Psychopharmacology|January 1, 1981
Effect of chronic amphetamine administration on central dopaminergic mechanisms in the vervetF Owen, H F Baker, R M Ridley, et al.Lancet (London, England)|July 29, 1978
Increased dopamine-receptor sensitivity in schizophreniaF Owen, A J Cross, T J Crow, et al.Life Sciences|August 22, 1983
77Br-p-bromospiperone: a ligand for in vivo labelling of dopamine receptorsF Owen, M Poulter, R D Mashal, et al.The British Journal of Psychiatry : the Journal of Mental Science|May 1, 1985
Tritiated etorphine and naloxone binding to opioid receptors in caudate nucleus in schizophreniaF Owen, R C Bourne, M Poulter, et al.Psychopharmacology|October 31, 1978
The activities of brain dopamine-beta-hydroxylase and catechol-O-methyl transferase in schizophrenics and controlsA J Cross, T J Crow, W S Killpack, et al.Archives of General Psychiatry|November 1, 1976
Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patientsF Owen, R Bourne, T J Crow, et al.Brain Research. Molecular Brain Research|March 1, 1992
A dementing illness associated with a novel insertion in the prion protein geneF Owen, M Poulter, J Collinge, et al.American Journal of Human Genetics|December 1, 1991
Presymptomatic detection or exclusion of prion protein gene defects in families with inherited prion diseasesJ Collinge, M Poulter, M B Davis, et al.Journal of Clinical Psychopharmacology|October 1, 1982
Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors?T J Crow, A J Cross, E C Johnstone, et al.Federation Proceedings|October 1, 1979
Catecholamine reward pathways and schizophrenia: the mechanism of the antipsychotic effect and the site of the primary disturbanceT J CrowPageof 61